Department of Cellular and Molecular Biology, Faculty of Biological Sciences, University of Sciences and Technology Houari Boumediene, P.B. 32 El-Alia, Bab-Ezzouar, 16111, Algiers, Algeria.
Microbiology Laboratory of the Burn Center, The Central Hospital of Army, BP 244 Kouba, Algiers, Algeria.
Burns. 2021 Dec;47(8):1833-1843. doi: 10.1016/j.burns.2021.03.005. Epub 2021 Mar 17.
To investigate the prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa (PA) producing extended-spectrum beta-lactamases (ESBLs) and metallo-beta-lactamases (MBLs) in burn patients in Algeria.
Between April 2016 and October 2019, 47 non-redundant isolates of PA were collected from 47 burn patients admitted to the Department of Burns at the Military Hospital of Algiers in Algeria. Antibiotic susceptibility testing was performed by agar diffusion and the Phoenix automated method. Resistance genes were identified by PCR, and molecular typing of isolates was carried out by enterobacterial repetitive intergenic consensus (ERIC) sequences-polymerase chain reaction (PCR).
Among the 47 non-redundant MDR PA strains isolated, 59.57% were phenotypically ESBLs-positive, and 100% were phenotypically MBL-positive. The ESBL-positive isolates were subsequently screened for six groups of bla genes encoding ESBL-type enzymes, namely blaCTX-M2, blaPER, blaTEM, blaSHV, blaVEB, and blaGES. Out of the 28 ESBL-producing strains, 23 (82.14%) were blaCTX-M2 positive; 18 (38.29%) were blaPER positive, and 16 (34.04%) were blaTEM positive, while 5 (17.9%) were co-harboring blaCTX-M2, blaTEM, and blaPER genes. The blaSHV, blaVEB, and blaGES genes were not detected in any of the ESBL positive isolates. Since all isolates were MBL-positive, all 47 strains were screened for the blaNDM-1, blaIMP, blaVIM genes that produce MBLs; however, none of these genes were detected. Additional screening for the oprD gene demonstrated that 45 (95.74%) of the isolates were positive for this gene. Finally, ERIC PCR revealed 11 distinct PA clones among the blaCTX-M2 positive strains.
This is the first study to report the presence of CTX-M2-producing PA in the North Africa region and the first to detect blaCTX-M2-positive and blaPER-positive PA clinical isolates in Algeria, therefore demonstrating the spread of such MDR strains to this part of the world. Identification of bacterial genotypic alterations that confer antibiotic resistance is critical in determining the most effective antimicrobial strategies to be employed. Therefore, our findings could potentially facilitate clinical decision making regarding the antibiotics of choice for the treatment of burn patients that suffer from PA infections in Algeria.
调查阿尔及利亚烧伤患者中产超广谱β-内酰胺酶(ESBLs)和金属β-内酰胺酶(MBLs)的多药耐药(MDR)铜绿假单胞菌(PA)的流行情况。
2016 年 4 月至 2019 年 10 月,从阿尔及利亚阿尔及尔军事医院烧伤科收治的 47 名烧伤患者中采集了 47 株非冗余的 PA 分离株。采用琼脂扩散法和 Phoenix 自动化方法进行抗生素药敏试验。通过 PCR 鉴定耐药基因,采用肠杆菌重复基因间一致性(ERIC)序列-聚合酶链反应(PCR)对分离株进行分子分型。
在所分离的 47 株非冗余 MDR PA 菌株中,59.57%为表型 ESBL 阳性,100%为表型 MBL 阳性。随后对 28 株产 ESBL 的菌株进行了 6 组 bla 基因编码 ESBL 型酶的筛选,即 blaCTX-M2、blaPER、blaTEM、blaSHV、blaVEB 和 blaGES。在 23 株产 ESBL 的菌株中,23 株(82.14%)blaCTX-M2 阳性;18 株(38.29%)blaPER 阳性,16 株(34.04%)blaTEM 阳性,5 株(17.9%)同时携带 blaCTX-M2、blaTEM 和 blaPER 基因。blaSHV、blaVEB 和 blaGES 基因在任何 ESBL 阳性分离株中均未检出。由于所有分离株均为 MBL 阳性,因此对所有 47 株菌进行了 blaNDM-1、blaIMP、blaVIM 基因检测,以筛选产生 MBL 的基因;然而,未检测到这些基因。对 oprD 基因的进一步筛选表明,45 株(95.74%)分离株该基因阳性。最后,ERIC-PCR 显示 blaCTX-M2 阳性菌株中有 11 种不同的 PA 克隆。
这是第一项在北非地区报道 CTX-M2 产 PA 的研究,也是首次在阿尔及利亚检测到 blaCTX-M2 阳性和 blaPER 阳性 PA 临床分离株,表明此类 MDR 菌株已传播到世界这一地区。鉴定赋予抗生素耐药性的细菌基因型改变对于确定最有效的抗菌策略至关重要。因此,我们的发现可能有助于临床决策,选择治疗在阿尔及利亚感染 PA 的烧伤患者的抗生素。